These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18413186)

  • 1. Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients.
    Valdivielso P; Ariza MJ; de la Vega-Román C; González-Alegre T; Rioja J; Ulzurrun E; González-Santos P
    J Diabetes Complications; 2008; 22(4):273-7. PubMed ID: 18413186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J; Todorova BR; Chiasson JL; Laakso M;
    J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic lipase polymorphism and increased risk of peripheral arterial disease.
    Eller P; Schgoer W; Mueller T; Tancevski I; Wehinger A; Ulmer H; Foeger B; Haltmayer M; Ritsch A; Patsch JR
    J Intern Med; 2005 Oct; 258(4):344-8. PubMed ID: 16164573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
    Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
    Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
    Zhan Q; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo E genotype, diabetes, and peripheral arterial disease in older men: the Honolulu Asia-aging study.
    Resnick HE; Rodriguez B; Havlik R; Ferrucci L; Foley D; Curb JD; Harris TB
    Genet Epidemiol; 2000 Jul; 19(1):52-63. PubMed ID: 10861896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.
    Schgoer W; Eller P; Mueller T; Tancevski I; Wehinger A; Ulmer H; Sandhofer A; Ritsch A; Haltmayer M; Patsch JR
    Clin Biochem; 2008 Jun; 41(9):712-6. PubMed ID: 18325332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
    Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST
    Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The linkage disequilibrium of four loci in hepatic lipase promoter gene of cerebral infarction patients in Shanghai].
    Fu Y; Ni PH; Ying YY; Liu JR; Song YJ; Xin XY; Guo ZL; Chen SD
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(31):2203-8. PubMed ID: 18001531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes.
    Liang H; Murase Y; Katuta Y; Asano A; Kobayashi J; Mabuchi H
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):317-22. PubMed ID: 16117820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
    Catalano M; Cortelazzo A; Santi R; Contino L; Demicheli M; Yilmaz Y; Zorzetto M; Campo I; Lanati N; Emanuele E
    Clin Biochem; 2008 Aug; 41(12):981-5. PubMed ID: 18538667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eNOS and ACE genes influence peripheral arterial disease predisposition in smokers.
    Sticchi E; Sofi F; Romagnuolo I; Pratesi G; Pulli R; Pratesi C; Abbate R; Fatini C
    J Vasc Surg; 2010 Jul; 52(1):97-102.e1. PubMed ID: 20478683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease.
    Yazdani-Biuki B; Krippl P; Brickmann K; Fuerst F; Langsenlehner U; Paulweber B; Pilger E; Wascher TC; Brezinschek HP; Renner W
    Angiology; 2010 Feb; 61(2):211-5. PubMed ID: 19625260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes.
    Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hanley AJ; Hegele RA
    Cardiovasc Diabetol; 2005 Nov; 4():17. PubMed ID: 16274479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan.
    Chou CK; Weng SW; Chang HW; Chen CY; Su SC; Liu RT
    Diabetes Res Clin Pract; 2008 Sep; 81(3):331-7. PubMed ID: 18639951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease.
    Catalano M; Cortelazzo A; Yilmaz Y; Perilli E; Carzaniga G; Emanuele E
    Clin Chim Acta; 2008 Jan; 387(1-2):109-12. PubMed ID: 17942087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between functional FABP2 promoter haplotype and type 2 diabetes.
    Li Y; Fisher E; Klapper M; Boeing H; Pfeiffer A; Hampe J; Schreiber S; Burwinkel B; Schrezenmeir J; Döring F
    Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.